Case report: isolated prevotella intermedia causing intracranial infection detected using metagenomic next generation

Zhinan Ye1, Jinfeng He1, Hailong Ji2

  • 1Department of Neurology, Municipal Hospital Affiliated to the Medical School of Taizhou University, Taizhou, Zhejiang Province, China.

BMC Neurology
|October 23, 2023
PubMed
Abstract

Insights

Metagenomic next-generation sequencing (mNGS) successfully identified Prevotella intermedia, a rare bacterium, in a Chinese patient with central nervous system infection. This advanced technique aids in diagnosing rare pathogens and guiding effective antibiotic treatment.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Genomics

Background:

  • Prevotella intermedia, a rare anaerobic bacterium, is seldom identified in clinical settings.
  • While linked to oral and genital infections, it has not been previously reported in cerebrospinal fluid (CSF) in China.
  • Anaerobic bacterial culture presents challenges for accurate pathogen detection.

Observation:

  • A 64-year-old Chinese woman presented with meningoencephalitis symptoms.
  • Standard CSF cultures did not identify the pathogen.
  • Magnetic resonance imaging revealed a left frontal parietal lobe abscess, suspected to be from an oral cavity infection, possibly due to dental surgery.

Findings:

  • Metagenomic next-generation sequencing (mNGS) of CSF detected isolated Prevotella intermedia.
  • The patient received broad-spectrum antibiotics including ceftriaxone, vancomycin, moxifloxacin, meropenem, metronidazole, and linezolid.
  • Surgical intervention was performed for the brain abscess.

Implications:

  • This case underscores the critical role of mNGS in diagnosing central nervous system infections.
  • mNGS facilitates the identification of uncommon pathogens in cases with unclear etiology.
  • Accurate diagnosis via mNGS and appropriate antibiotic therapy are vital for patient recovery and preventing severe outcomes.